Aldeyra Therapeutics, Inc. (ALDX)
4.65
-0.54
(-10.49%)
USD |
NASDAQ |
Mar 05, 16:00
4.59
-0.06
(-1.29%)
After-Hours: 07:50
Aldeyra Therapeutics Cash from Financing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -0.007M |
| MediciNova, Inc. | 0.244M |
| Altimmune, Inc. | -- |
| AbbVie, Inc. | -4.166B |
| Actinium Pharmaceuticals, Inc. | -0.209M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.299M |
| Cash from Investing (Quarterly) | 16.00M |
| Free Cash Flow | -33.35M |
| Free Cash Flow Per Share (Quarterly) | -0.0881 |
| Free Cash Flow to Equity (Quarterly) | -5.286M |
| Free Cash Flow to Firm (Quarterly) | -4.824M |
| Free Cash Flow Yield | -11.94% |